LANSOPRAZOLE for Atrial fibrillation: Side Effects & Safety Data

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

There are 343 adverse event reports in the FDA FAERS database where LANSOPRAZOLE was used for Atrial fibrillation.

Most Reported Side Effects for LANSOPRAZOLE

Side Effect	Reports	%	Deaths	Hosp.
Chronic kidney disease	32,517	53.4%	3,554	2,363
Acute kidney injury	16,359	26.9%	2,355	2,304
Renal failure	12,509	20.5%	2,354	1,860
End stage renal disease	9,734	16.0%	2,217	1,183
Renal injury	9,383	15.4%	808	986
Tubulointerstitial nephritis	3,860	6.3%	569	504
Death	2,517	4.1%	2,513	294
Gastrooesophageal reflux disease	2,482	4.1%	122	352
Off label use	2,183	3.6%	434	782
Nephrogenic anaemia	2,162	3.6%	392	576
Renal impairment	2,063	3.4%	264	357
Hyperchlorhydria	1,983	3.3%	108	27
Rebound acid hypersecretion	1,713	2.8%	231	187
Diarrhoea	1,674	2.8%	197	774
Pain	1,662	2.7%	160	394